CAPMATINIB 200MG TABLETS
$1,490.00Price
Capmatinib 200mg Tablet is a targeted cancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It is used for the treatment of adults with advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have a specific genetic alteration known as MET exon 14 skipping mutation. Capmatinib works by blocking abnormal MET signalling pathways that contribute to cancer cell growth and multiplication. This medicine should be taken strictly under the supervision of a qualified oncologist. A valid prescription is required.

